Intensive Discharge Intervention in Diabetes

Completed · Not applicable

Conditions studied: Type II Diabetes, Cardiovascular Disease

In brief

The goal of this study is to design and implement an intensive discharge intervention for inpatients with type 2 diabetes and cardiovascular disease, and determine the effects of the intervention on post-discharge insulin adherence, glycemic control, cardiac medication adherence, hypoglycemic events, and emergency department visits and hospital readmissions.

Key facts

Study ID: NCT02122926
Run by: Brigham and Women's Hospital
People needed: 180
Starts: 2011-12-01
Expected to finish: 2013-07-01
Last updated by the study team: 2014-04-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Adult inpatients at BWH on the medicine or cardiology services with a primary care physician who belongs to a participating practice or has not explicitly opted out of the study
Type 2 diabetes
Active cardiovascular disease
Likely to be discharged home, and one of the following:
prescribed insulin prior to admission
prescribed two oral agents and with an A1c > 8.0 within 30 days of admission. - Practices that have already agreed to participate in this study for all their eligible patients.

You may not qualify if…

Discharge to a location other than home or rehabilitation (or to a caregiver's home)
Patient does not administer own medications and absence of a caregiver who lives with patient and administers all medications
Police custody, no telephone or homeless
Previous enrolment in the study within 90 days of discharge
Patient unable to communicate in either English or Spanish
Participation in the Integrated Care Management Program (iCMP)

Where it is running

Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.